Posted , 3 users are following.
I was Put on Atenolol about 15 years ago and it seemed to help. I was down to 1 or 2 episodes a year. Now it is not manufactured anymore for some reason. I am now on Metoprotol now. Does not seem as effective.
0 likes, 2 replies
We want the community to be a useful resource for our users but it is important to remember that the community are not moderated or reviewed by doctors and so you should not rely on opinions or advice given by other users in respect of any healthcare matters. Always speak to your doctor before acting and in cases of emergency seek appropriate medical assistance immediately. Use of the community is subject to our Terms of Use and Privacy Policy and steps will be taken to remove posts identified as being in breach of those terms.
derek76 terry05806
Posted
There has been a shortage in America for a few months and there are various stories around as to why.
The FDA website lists four manufacturers who say shortage of the active ingredient until February 2018. Another says that there was a product recall with one maker due to a manufacturing problem.
In the UK:
I can’t put a link to the site but it involves about 30 different drugs including Atenolol. All unexpired stock of the above products is being recalled to pharmacy, clinic and wholesaler level, irrespective of pack configuration, batch number and expiry date.
This is a precautionary recall following a routine inspection of the manufacturing site in India. The inspection identified deficiencies in good manufacturing practice (GMP) and the GMP certificate for this site has been withdrawn.
These products have been tested on importation and Qualified Person (QP) released. There is no evidence of a risk to patient safety from products currently in the UK market; however it is considered that the products have not been manufactured in line with GMP requirements.
No further products should be supplied. Products from alternatives suppliers are available in the majority of cases, either in equivalent strengths or varying strengths. Where there are no alternative suppliers therapeutic alternatives should be selected according to clinical practice.
Remaining stocks of the affected batches should be quarantined and returned to the original supplier for credit. For enquiries relating to stock returns please contact Wockhardt UK Ltd Customer services..
MHRA is working with Wockhardt UK Ltd to ensure supply is resumed as quickly as possible; at this time there is no indication as to when new stock of these Wockhardt UK Ltd products is likely to be available.
Recipients of this drug alert should bring it to the attention of relevant contacts by copy of this letter. Local area teams are asked to forward this to relevant clinics, general practitioners and community pharmacists for information.
terry05806 derek76
Posted